Answer
It is unknown whether tisagenlecleucel cells pass into human breast milk; risk to the breast-fed infant cannot be excluded, women should be advised of this potential risk, and breast-feeding after Kymriah should be discussed with the treating physician.
Sources for this answer
- Kymriah cells dispersion for infusionNovartis Pharmaceuticals UK Ltd · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 15Document updated
Sources checked